Chapter title |
Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation
|
---|---|
Chapter number | 31 |
Book title |
Serum/Plasma Proteomics
|
Published in |
Methods in molecular biology, July 2017
|
DOI | 10.1007/978-1-4939-7057-5_31 |
Pubmed ID | |
Book ISBNs |
978-1-4939-7056-8, 978-1-4939-7057-5
|
Authors |
Santosh D. Bhosale, Robert Moulder, Petri Kouvonen, Riitta Lahesmaa, David R. Goodlett |
Editors |
David W. Greening, Richard J. Simpson |
Abstract |
Blood protein measurements are used frequently in the clinic in the assessment of patient health. Nevertheless, there remains the need for new biomarkers with better diagnostic specificities. With the advent of improved technology for bioanalysis and the growth of biobanks including collections from specific disease risk cohorts, the plasma proteome has remained a target of proteomics research toward the characterization of disease-related biomarkers. The following protocol presents a workflow for serum/plasma proteomics including details of sample preparation both with and without immunoaffinity depletion of the most abundant plasma proteins and methodology for selected reaction monitoring mass spectrometry validation. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 37 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 7 | 19% |
Student > Doctoral Student | 4 | 11% |
Student > Ph. D. Student | 4 | 11% |
Other | 3 | 8% |
Researcher | 3 | 8% |
Other | 5 | 14% |
Unknown | 11 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 8 | 22% |
Agricultural and Biological Sciences | 4 | 11% |
Medicine and Dentistry | 4 | 11% |
Chemistry | 3 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Other | 4 | 11% |
Unknown | 13 | 35% |